Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1237 Harding Pl
Ste 3100
Charlotte, NC 28204Phone+1 704-373-0212
Education & Training
- University of ColoradoChief Residency, Internal Medicine, 2012
- Abbott-Northwestern Hospital/Allina Health SystemFellowship, Adult Congenital Heart Disease, 2017 - 2018
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Interventional Cardiology, 2016 - 2017
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2013 - 2016
- University of ColoradoResidency, Internal Medicine, 2010 - 2012
- University of ColoradoInternship, Internal Medicine, 2009 - 2010
- University of Minnesota Medical SchoolClass of 2009
Certifications & Licensure
- CA State Medical License 2013 - Present
- NC State Medical License 2018 - 2025
- SC State Medical License 2020 - 2025
- MN State Medical License 2016 - 2018
- CO State Medical License 2011 - 2015
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 24 citationsLong-Term Marathon Running Is Associated with Low Coronary Plaque Formation in Women.William O. Roberts, Robert S. Schwartz, Stacia Merkel Kraus, Jonathan G. Schwartz, Gretchen Peichel
Medicine and Science in Sports and Exercise. 2017-04-01 - 17 citationsThe right atrium and tricuspid annulus are cardinal structures in tricuspid regurgitation with or without pulmonary hypertensionNaohiko Nemoto, Jonathan G. Schwartz, John R. Lesser, Wesley D. Pedersen, Paul Sorajja
International Journal of Cardiology. 2017-03-01 - 49 citationsIncreased Coronary Artery Plaque Volume Among Male Marathon Runners.Robert S. Schwartz, Stacia Merkel Kraus, Jonathan G. Schwartz, Kelly Wickstrom, Gretchen Peichel
Missouri Medicine. 2014-03-01
Press Mentions
- Evidence of TAVR Benefit Extends to Cardiogenic ShockMay 18th, 2023
- AFib Patients Better off with No Antiplatelet After TAVRMarch 29th, 2020
- Rocket Pharmaceuticals Presents Preclinical Data of RP-A501 for Danon Disease at the American Society of Gene and Cell Therapy 2019 Annual MeetingMay 2nd, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: